UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

UCD19 CAR T Therapy in Adults With B-ALL and MRD Positivity in CR1 — Stella

Home/Acute Lymphoid Leukemia/

View on ClinicalTrials.gov

Recruiting

Back to Acute Lymphoid Leukemia trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

University of Colorado Hospital, Aurora, Colorado

Key details

Phase

Early testing

Sponsor

University of Colorado, Denver

Enrollment target

~29 participants

Started

January 2024

Primary completion

June 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.